Halofantrine 69756-53-2
Halofantrine is a drug used to treat malaria. Halofantrine's structure contains a substituted phenanthrene, and is related to the antimalarial drugs quinine and lumefantrine. Marketed as Halfan, halofantrine is never used to prevent malaria and its mode of action is unknown.
| Systematic (IUPAC) name: |
3-dibutylamino-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]-propan-1-ol |
| Halofantrine CAS number: |
69756-53-2 |
| ATC code: |
P01BX01 |
| PubChem: |
37393 |
| DrugBank: |
APRD00419 |
| Formula: |
C26H30Cl2F3NO |
| Molecular mass: |
500.423 g/mol |
| Halofantrine Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
